华兰生物(002007) - 2024 Q1 - 季度财报

Revenue and Profit Performance - Revenue for Q1 2024 decreased by 10.60% to 787,309,418.97 yuan compared to the same period last year[3] - Net profit attributable to shareholders decreased by 25.56% to 261,773,937.60 yuan year-over-year[3] - Total revenue for Q1 2024 was 787.31 million yuan, a decrease of 10.6% compared to 880.66 million yuan in the same period last year[13] - Net profit attributable to the parent company was 261.77 million yuan, down 25.6% from 351.68 million yuan in the previous year[14] - Total comprehensive income for Q1 2024 was 274.37 million yuan, down 28.2% from 382.37 million yuan in the same period last year[15] - Minority shareholders' comprehensive income was 12.60 million yuan, a decrease of 58.9% from 30.69 million yuan in the previous year[15] Cash Flow and Financial Activities - Operating cash flow decreased significantly by 86.41% to 50,186,473.40 yuan[3] - Investment cash flow increased by 91.30% due to higher cash received from investment returns[6] - Financing cash flow surged by 4,204.00% due to increased borrowing[6] - Sales of goods and services received cash of 1,154,184,261.52 yuan, an increase from the previous period's 1,104,207,859.33 yuan[16] - Total cash inflows from operating activities were 1,172,761,540.31 yuan, up from 1,117,938,939.26 yuan in the previous period[16] - Cash paid for goods and services was 530,413,604.37 yuan, significantly higher than the previous period's 301,422,954.86 yuan[16] - Net cash flow from operating activities was 50,186,473.40 yuan, a decrease from 369,227,788.51 yuan in the previous period[17] - Cash received from investment returns was 50,526,012.48 yuan, up from 24,969,046.41 yuan in the previous period[17] - Net cash flow from investment activities was -64,142,690.50 yuan, an improvement from -737,127,823.13 yuan in the previous period[17] - Net cash flow from financing activities was 193,338,305.81 yuan, a significant increase from -4,710,975.73 yuan in the previous period[17] - Total cash and cash equivalents at the end of the period were 1,168,607,650.23 yuan, up from 724,044,419.94 yuan in the previous period[17] Assets and Liabilities - Total assets increased slightly by 1.01% to 16,268,787,833.04 yuan compared to the end of the previous year[3] - Shareholders' equity increased by 2.39% to 11,631,477,522.62 yuan[3] - The company's monetary funds increased to 1,170,608,928.52 yuan, up from 993,767,308.91 yuan at the beginning of the period[11] - Trading financial assets rose to 3,148,759,475.63 yuan, compared to 2,114,825,797.42 yuan at the start of the period[11] - Accounts receivable decreased to 2,103,541,671.36 yuan from 2,295,645,462.97 yuan at the beginning of the period[11] - Inventory increased to 1,923,370,621.37 yuan, up from 1,673,627,088.65 yuan at the start of the period[12] - Total current assets amounted to 9,856,286,286.62 yuan, compared to 9,326,541,857.42 yuan at the beginning of the period[12] - Fixed assets stood at 2,043,970,541.27 yuan, slightly down from 2,055,070,356.28 yuan at the start of the period[12] - Construction in progress increased to 724,917,405.97 yuan, up from 661,513,007.72 yuan at the beginning of the period[12] - Total non-current assets were 6,412,501,546.42 yuan, down from 6,779,241,437.77 yuan at the start of the period[12] - Total assets reached 16,268,787,833.04 yuan, compared to 16,105,783,295.19 yuan at the beginning of the period[12] - Short-term borrowings increased to 800,000,000.00 yuan, up from 700,350,000.00 yuan at the start of the period[12] - Total liabilities increased to 2.56 billion yuan, up from 2.68 billion yuan in the previous quarter[13] - Total equity attributable to the parent company was 11.63 billion yuan, an increase of 2.4% from 11.36 billion yuan in the previous quarter[13] Expenses and Income - Financial expenses decreased by 335.35% due to increased interest income[6] - Other income increased by 34.22% due to higher government subsidies[6] - R&D expenses for Q1 2024 were 72.71 million yuan, a decrease of 6.3% compared to 77.58 million yuan in the same period last year[14] - Sales expenses decreased by 29.3% to 44.73 million yuan compared to 63.24 million yuan in the same period last year[14] - Financial income for Q1 2024 was 7.67 million yuan, a significant increase from 3.30 million yuan in the previous year[14] Shareholder Information - The top shareholder, An Kang, holds 17.85% of the company's shares[7] - Basic earnings per share for Q1 2024 were 0.1431 yuan, down from 0.1928 yuan in the previous year[15] Miscellaneous - The company's first-quarter report was not audited[18]